Primary Record
Didromycin
- In stock
- 7,400 g
- Purity
- 98.2 %
- CAS
- 5490-27-7
Compound Identifiers & Properties
- CAS
- 5490-27-7
- PubChem CID
- 6419912
- SMILES
- C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H]([C@@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(CO)O.C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@H]2[C@@H]([C@H]([C@@H]([C@H]([C@@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(CO)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O
- Canonical SMILES
- CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](O)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3N=C(N)N)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O.CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](O)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3N=C(N)N)O[C@@H](C)[C@]2(O)CO)O[C@@H](CO)[C@H](O)[C@H]1O.O=S(=O)(O)O.O=S(=O)(O)O.O=S(=O)(O)O
Names & Synonyms
- Didromycin
- Didromycine
- squisulfate
- Panstreptin
- Abiocine
- Dihydrostreptomycin sulfate
- Prestwick_173
- Dihydrostreptomyzinsulfat
- DIHYDROSTREPTOMYCIN SESQUISULFATE
- Dihydrostreptomycin sulphate
- AC1O4WG8
- UNII-T7D4876IUE
- Dihydrostreptomycin 3/2 sulfate
- Dihydrostreptomycinium sulfuricum
- CHEMBL4303534
- Dihydrostreptomycin Sulfate [USP]
- HMS1568O20
- HMS2095O20
- HMS3712O20
- C42H88N14O36S3
- EINECS 226-823-7
- MFCD00070252
- AKOS030504208
- CCG-220159
- CID6419912
- 2C21H41N7O12.3H2O4S
- 5490-27-7
- Dihydrostreptomycin sulfate (2:3)(salt)
- AS-16028
- C21H41N7O12.3/2H2O4S
- R893
- AI3-50133
- Streptomycin, dihydro-, sulfate (2:3) (salt)
- C21-H41-N7-O12.3/2H2-O4-S
- Dihydrostreptomycin sesquisulfate, >=95% (HPLC)
- SR-01000872635
- SR-01000872635-1
- xy)-2,5,6-trihydroxycyclohexane-1,3-diyl)diguanidine se
- Dihydrostreptomycin sulfate, European Pharmacopoeia (EP) Reference Standard
- Dihydrostreptomycin sesquisulfate, BioReagent, suitable for cell culture, >=98% (TLC)
- Dihydrostreptomycin Sulfate, Pharmaceutical Secondary Standard; Certified Reference Material
- Dihydrostreptomycin sulfate, United States Pharmacopeia (USP) Reference Standard
- 1,1'-((1S,2S,3R,4S,5S,6R)-4-(((2R,3R,4R,5S)-3-(((2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)tetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-4-(hydroxymethyl)-5-methyltetrahydrofuran-2-yl)o
- 1,1'-((1S,2S,3R,4S,5S,6R)-4-(((2R,3R,4R,5S)-3-(((2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)tetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-4-(hydroxymethyl)-5-methyltetrahydrofuran-2-yl)oxy)-2,5,6-trihydroxycyclohexane-1,3-diyl)diguanidine sesquisulfate
- 2-[(1R,2S,3S,4R,5S,6S)-2-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)tetrahydropyran-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyl-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine;sulfuric acid
- 2-[(1S,2S,3R,4S,5S,6R)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine; sulfuric acid
- 2-[(1S,2S,3R,4S,5S,6R)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;sulfuric acid
- D-estreptamina, o-2-deoxi-2-(metilamino)-?-l-glucopiranosil-(1?2)-o-5-deoxi-3-c-(hidroximetil)-?-l-lixofuranosil-(1?4)-n1,n3-bis(aminoiminometil)-, sulfato (2:3)
- D-Streptamine, O-2-deoxy-2-(methylamino)-.alpha.-L-glucopyranosyl-(1.fwdarw.2)-O-5-deoxy-3-C-(hydroxymethyl)-.alpha.-L-lyxofuranosyl-(1.fwdarw.4)-N,N'-bis(aminoiminomethyl)-, sulfate (2:3) (salt)
- D-Streptamine, O-2-deoxy-2-(methylamino)-.alpha.-L-glucopyranosyl-(1?2)-O-5-deoxy-3-C-(hydroxymethyl)-.alpha.-L-lyxofuranosyl-(1?4)-N,N'-bis(aminoiminomethyl)-, sulfate (2:3) (salt)